Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis

Autoimmunity

Volumn 39, Issue 3, 2006, Pages 171-176

  Chevrel, G ^a   Page, G ^a   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Chemokines; Cytokines; Dendritic cells; Idiopathic inflammatory myopathies; T cells

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AUTOANTIBODY; GAMMA INTERFERON; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DERMATOMYOSITIS; HUMAN; IMMUNE RESPONSE; MOLECULAR MECHANICS; MYOSITIS; NONHUMAN; PATHOGENESIS; POLYMYOSITIS; REVIEW; RISK FACTOR; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; DERMATOMYOSITIS; HUMANS; MUSCLES; MYOSITIS; POLYMYOSITIS; T-LYMPHOCYTES;

EID: 33745108124     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930600622173     Document Type: Review

References (61)

1. Dalakas, MC. (1991) Polymyositis, dermatomyositis and inclusion-body myositis N Engl J Med, 325, pp. 1487-1498.
2. Lundberg, I and Chung, Y. (2000) Treatment and investigation of idiopathic inflammatory myopathies Rheumatology (Oxford), 39, pp. 7-17.
3. Dalakas, MC. (2001) The molecular and cellular pathology of inflammatory muscle diseases Curr Opin Pharmacol, 1, pp. 300-306.
4. Dalakas, MC. (2003) Therapeutic approaches in patients with inflammatory myopathies Semin Neurol, 23, pp. 199-206.
5. Targoff, IN. (2002) Idiopathic inflammatory myopathy: Autoantibody update Curr Rheumatol Rep, 4, pp. 434-441.
6. Howard, OM and Dong, HF and Yang, D and Raben, N and Nagaraju, K and Rosen, A and Casciola-Rosen, L and Hartlein, M and Kron, M and Yiadom, K and Dwivedi, S and Plotz, PH and Oppenheim, JJ. (2002) Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells J Exp Med, 196, pp. 781-791.
7. Ytterberg, SR. (1996) Infectious agents associated with myopathies Curr Opin Rheumatol, 8, pp. 507-513.
8. Leff, RL and Love, LA and Miller, FW and Greenberg, SJ and Klein, EA and Dalakas, MC and Plotz, PH. (1992) Viruses in idiopathic inflammatory myopathies: Absence of candidate viral genomes in muscle Lancet, 339, pp. 1192-1195.
9. Chevrel, G and Calvet, A and Belin, V and Miossec, P. (2000) Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle Rheumatology (Oxford), 39, pp. 1037-1039.
10. Chevrel, G and Borsotti, JP and Miossec, P. (2003) Lack of evidence for a direct involvement of muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies. A follow-up study Rheumatology, 42, pp. 349-352.
11. Steinman, RM. (1991) The dendritic cell system and its role in immunogenicity Ann Rev Immunol, 9, pp. 271-296.
12. Goebels, N and Michaelis, D and Wekerle, H and Hohlfeld, R. (1992) Human myoblasts as antigen-presenting cells J Immunol, 149, pp. 661-667.
13. Curnow, J and Corlett, L and Willcox, N and Vincent, A. (2001) Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response J Neuroimmunol, 115, pp. 127-134.
14. Wiendl, H and Lautwein, A and Mitsdorffer, M and Krause, S and Erfurth, S and Wienhold, W and Morgalla, M and Weber, E and Overkleeft, HS and Lochmuller, H and Melms, A and Tolosa, E and Driessen, C. (2003) Antigen processing and presentation in human muscle: Cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies J Neuroimmunol, 138, pp. 132-143.
15. Banchereau, J and Steinman, RM. (1998) Dendritic cells and the control of immunity Nature, 392, pp. 245-252.
16. Pimorady-Esfahani, A and Grounds, MD and McMenamin, PG. (1997) Macrophages and dendritic cells in normal and regenerating murine skeletal muscle Muscle Nerve, 20, pp. 158-166.
17. Thompson, AG and Pettit, AR and Padmanabha, J and Mansfield, H and Frazer, IH and Strutton, GM and Thomas, R. (2002) Nuclear RelB+ cells are found in normal lymphoid organs and in peripheral tissue in the context of inflammation, but not under normal resting conditions Immunol Cell Biol, 80, pp. 164-169.
18. Kawachi, I and Tanaka, K and Tanaka, M and Tsuji, S. (2001) Dendritic cells presenting pyruvate kinase M1/M2 isozyme peptide can induce experimental allergic myositis in BALB/c mice J Neuroimmunol, 117, pp. 108-115.
19. Page, G and Chevrel, G and Miossec, P. (2004) Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokineyproducing cells Arthritis Rheum, 50, pp. 199-208.
20. Caux, C and Massacrier, C and Vanbervliet, B and Dubois, B and de Saint-Vis, B and Dezutter-Dambuyant, C and Jacquet, C and Schmitt, D and Banchereau, J. (1997) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha Adv Exp Med Biol, 417, pp. 21-25.
21. de Saint-Vis, B and Vincent, J and Vandenabeele, S and Vanbervliet, B and Pin, JJ and Ait-Yahia, S and Patel, S and Mattei, MG and Banchereau, J and Zurawski, S and Davoust, J and Caux, C and Lebecque, S. (1998) A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment Immunity, 9, pp. 325-336.
22. Zhou, LJ and Tedder, TF. (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily J Immunol, 154, pp. 3821-3835.
23. Arahata, K and Engel, AG. (1988) Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis Ann Neurol, 23, pp. 168-173.
24. Nyberg, P and Wikman, AL and Nennesmo, I and Lundberg, I. (2000) Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis J Rheumatol, 27, pp. 940-948.
25. Hohlfeld, R and Engel, AG. (1994) The immunobiology of muscle Immunol Today, 15, pp. 269-274.
26. Hohlfeld, R and Engel, AG. (1990) Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation J Clin Invest, 86, pp. 370-374.
27. Wiendl, H and Mitsdoerffer, M and Hofmeister, V and Wischhusen, J and Weiss, EH and Dichgans, J and Lochmuller, H and Hohlfeld, R and Melms, A and Weller, M. (2003) The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: Implications for myoblast transplantation and gene therapy Brain, 126, pp. 176-185.
28. Benveniste, O and Cherin, P and Maisonobe, T and Merat, R and Chosidow, O and Mouthon, L and Guillevin, L and Flahault, A and Burland, MC and Klatzmann, D and Herson, S and Boyer, O. (2001) Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients J Immunol, 167, pp. 3521-3529.
29. Mantegazza, R and Andreetta, F and Bernasconi, P and Baggi, F and Oksenberg, JR and Simoncini, O and Mora, M and Cornelio, F and Steinman, L. (1993) Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection J Clin Invest, 91, pp. 2880-2886.
30. O'Hanlon, TP and Dalakas, MC and Plotz, PH and Miller, FW. (1994) Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies J Immunol, 152, pp. 2569-2576.
31. Nishio, J and Suzuki, M and Miyasaka, N and Kohsaka, H. (2001) Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis J Immunol, 167, pp. 4051-4058.
32. Choi, YC and Dalakas, MC. (2000) Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies Neurology, 54, pp. 65-71.
33. Cherin, P and Herson, S and Crevon, MC and Hauw, JJ and Cervera, P and Galanaud, P and Emilie, D. (1996) Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis J Rheumatol, 23, pp. 1135-1142.
34. Lundberg, I and Brengman, JM and Engel, AG. (1995) Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls J Neuroimmunol, 63, pp. 9-16.
35. Tews, DS and Goebel, HH. (1996) Cytokine expression profile in idiopathic inflammatory myopathies J Neuropathol Exp Neurol, 55, pp. 342-347.
36. Lepidi, H and Frances, V and Figarella-Branger, D and Bartoli, C and Machado-Baeta, A and Pellissier, JF. (1998) Local expression of cytokines in idiopathic inflammatory myopathies Neuropathol Appl Neurobiol, 24, pp. 73-79.
37. Lundberg, I and Ulfgren, AK and Nyberg, P and Andersson, U and Klareskog, L. (1997) Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies Arthritis Rheum, 40, pp. 865-874.
38. Confalonieri, P and Bernasconi, P and Megna, P and Galbiati, S and Cornelio, F and Mantegazza, R. (2000) Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies J Neuropathol Exp Neurol, 59, pp. 164-169.
39. Adams, EM and Kirkley, J and Eidelman, G and Dohlman, J and Plotz, PH. (1997) The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases Proc Assoc Am Physicians, 109, pp. 275-285.
40. Chevrel, G and Page, G and Granet, C and Streichenberger, N and Varennes, A and Miossec, P. (2003) Interleukin-17 increases the effects of IL-1 beta on muscle cells: Arguments for the role of T cells in the pathogenesis of myositis J Neuroimmunol, 137, pp. 125-133.
41. Jovanovic, DV and Di Battista, JA and Martel-Pelletier, J and Jolicoeur, FC and He, Y and Zhang, M and Mineau, F and Pelletier, JP. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines J Immunol, 160, pp. 3513-3521.
42. Chabaud, M and Fossiez, F and Taupin, JL and Miossec, P. (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines J Immunol, 161, pp. 409-414.
43. Leon-Monzon, M and Dalakas, M. (1994) Interleukin-1 (IL-1) is toxic to human muscle Neurology, 44, pp. 132. suppl
44. Kalovidouris, AE and Plotkin, Z. (1995) Synergistic cytotoxic effect of interferon-gamma and tumor necrosis factor-alpha on cultured human muscle cells J Rheumatol, 22, pp. 1698-1703.
45. Shelton, GD and Calcutt, NA and Garrett, RS and Gu, D and Sarvetnick, N and Campana, WM and Powell, HC. (1999) Necrotizing myopathy induced by overexpression of IFN-g in transgenic mice Muscle Nerve, 22, pp. 156-165.
46. Dieu, MC and Vanbervliet, B and Vicari, A and Bridon, JM and Oldham, E and Ait-Yahia, S and Briere, F and Zlotnik, A and Lebecque, S and Caux, C. (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites J Exp Med, 188, pp. 373-386.
47. Wiendl, H and Mitsdoerffer, M and Schneider, D and Melms, A and Lochmuller, H and Hohlfeld, R and Weller, M. (2003) Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: Implications for the pathogenesis of inflammatory myopathies Brain, 126, pp. 1026-1035.
48. Ngo, VN and Tang, HL and Cyster, JG. (1998) Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells J Exp Med, 188, pp. 181-191.
49. Caux, C and Massacrier, C and Dubois, B and Valladeau, J and Dezutter-Dambuyant, C and Durand, I and Schmitt, D and Saeland, S. (1999) Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors J Leukoc Biol, 66, pp. 781-791.
50. Maini, RN and Breedveld, FC and Kalden, JR and Smolen, JS and Davis, D and Macfarlane, JD and Antoni, C and Leeb, B and Elliott, MJ and Woody, JN and Schaible, TF and Feldmann, M. (1998) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum, 41, pp. 1552-1563.
51. Lipsky, PE and van der Heijde, DM and St Clair, EW and Furst, DE and Breedveld, FC and Kalden, JR and Smolen, JS and Weisman, M and Emery, P and Feldmann, M and Harriman, GR and Maini, RN. (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis N Engl J Med, 343, pp. 1594-1602. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
52. Weinblatt, ME and Keystone, EC and Furst, DE and Moreland, LW and Weisman, MH and Birbara, CA and Teoh, LA and Fischkoff, SA and Chartash, EK. (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial Arthritis Rheum, 48, pp. 35-45.
53. De Bleecker, JL and Meire, VI and Declercq, W and Van Aken, EH. (1999) Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies Neuromuscul Disord, 9, pp. 239-246.
54. Kuru, S and Inukai, A and Liang, Y and Doyu, M and Takano, A and Sobue, G. (2000) Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis Acta Neuropathol (Berl), 99, pp. 585-588.
55. Kuru, S and Inukai, A and Kato, T and Liang, Y and Kimura, S and Sobue, G. (2003) Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies Acta Neuropathol (Berl), 105, pp. 217-224.
56. Chabaud, M and Miossec, P. (2001) The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model Arthritis Rheum, 44, pp. 1293-1303.
57. Chabaud, M and Page, G and Miossec, P. (2001) Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: Regulation by soluble receptors and Th2 cytokines J Immunol, 167, pp. 6015-6020.
58. Lundberg, I and Kratz, AK and Alexanderson, H and Patarroyo, M. (2000) Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis Arthritis Rheum, 43, pp. 336-348.
59. Ulfgren, AK and Grundtman, C and Borg, K and Alexanderson, H and Andersson, U and Harris, HE and Lundberg, IE. (2004) Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids Arthritis Rheum, 50, pp. 1586-1594.
60. Levine, TD. (2005) Rituximab in the treatment of dermatomyositis: An open-label pilot study Arthritis Rheum, 52, pp. 601-607.
61. Chevrel, G and Granet, C and Miossec, P. (2005) Contribution of TNF alpha and IL-1 beta to IL-6 production, NF-κB nuclear translocation and class I MHC expression in muscle cells: In vitro regulation with specific cytokine inhibitors Ann Rheum Dis, pp. 1257-1262.